Quick Takeaways: Why It Matters? ECO’s licence of Vaxinano’s late‑stage sheep toxoplasmosis vaccine gives it a low‑cost, de‑risked way to add a high‑value preventative product that directly tackles a major cause of abortion and lamb losses, with peak sales estimated a...
Quick Takeaways: Why It Matters? IDEXX’s Catalyst proBNP brings a well‑known heart‑disease blood test into the vet clinic with results in minutes, so vets can spot hidden heart problems, decide quickly in breathing emergencies, and monitor patients without waiting day...
Quick Takeaways: Why It Matters? Boehringer Ingelheim’s purchase of Evax gives it a promising new way to treat common horse allergies with longer‑lasting vaccines instead of short‑term symptom relief, which could mean fewer vet visits and better outcomes for owners. If the approach works a...
Featured Article Cover Story Research Development Product Launch Clinical Trial Results The Farmer’s Dog to Acquire Woof, Expanding Into Canine Wellness and Enrichment Strategic Acquisition The Farmer’s Dog will acquire Woof, the pet wellness company behind functional enrichment products s...
Quick Takeaways: Why It Matters? The authorization expands Elanco’s screwworm portfolio beyond Negasunt Powder and Tanidil (earlier emergency tools) and complements EPA‑registered Catron IV, creating a more complete prevention-plus-treatment toolkit as USDA tracks dozens of animal cases an...
Quick Takeaways: Why It Matters? With 138 horses across eight practices showing significantly better outcomes and nearly triple the odds of returning to prior performance, the data should help veterinarians justify using equicenta CTM as a convenient, regenerative alternative to harvesting...
Quick Takeaways: Why It Matters? Combining a subscription meal platform with Woof’s refillable enrichment systems (like the Pupsicle) should raise average customer lifetime value, improve retention, and create more cross-sell opportunities in a competitive DTC pet market. Keeping Woof as a...
Quick Takeaways: Why It Matters? If the science holds up, this could open a future premium category for hypoallergenic dogs and related breeding or licensing programs, creating new value in the pet biotech space while also raising major regulatory, ethical, and animal-welfare h...
Quick Takeaways: Why It Matters? The launch should help Zomedica make PulseVet easier to use in everyday practice by improving patient and staff comfort, potentially reducing anxiety-driven resistance and making clinics more willing to adopt or keep using shock wave therapy for equine and ...
Quick Takeaways: Why It Matters? By unifying Saladpet and Dogibogi under Kinfora, LIMPID should improve user retention, cross-sell higher-margin nutrition products, and gather denser longitudinal data that can support its “digital twin” ambition and future AI biomarker work in chronic dise...
